Home
University of Bergen
Dennis WT Nilsen's picture

Dennis WT Nilsen

Emeritus
Department of Clinical Science
  • E-maildennis.nilsen@uib.no
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
    5009 Bergen
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Show author(s) (2023). Total Bilirubin Yields Prognostic Information Following a Myocardial Infarction in the Elderly. Antioxidants.
  • Show author(s) (2022). The Effect of Protease-Activated Receptor-1 (PAR-1) Inhibition on Endothelial-Related Biomarkers in Patients with Coronary Artery Disease. Thrombosis and Haemostasis. 12 pages.
  • Show author(s) (2022). Podocan and Adverse Clinical Outcome in Patients Admitted With Suspected Acute Coronary Syndromes. Frontiers in Cardiovascular Medicine. 1-9.
  • Show author(s) (2022). Changes in eicosapentaenoic acid and docosahexaenoic acid and risk of cardiovascular events and atrial fibrillation: A secondary analysis of the OMEMI trial. Journal of Internal Medicine. 637-647.
  • Show author(s) (2021). Serum levels of dihomo-gamma (γ)-linolenic acid (dgla) are inversely associated with linoleic acid and total death in elderly patients with a recent myocardial infarction. Nutrients. 1-13.
  • Show author(s) (2021). Incidence and risk factors for major bleeding among patients undergoing percutaneous coronary intervention: Findings from the Norwegian Coronary Stent Trial (NORSTENT). PLOS ONE.
  • Show author(s) (2021). Complement component 7 is associated with total- and cardiac death in chest-pain patients with suspected acute coronary syndrome. BMC Cardiovascular Disorders. 1-12.
  • Show author(s) (2021). Angiopoietin-2 and angiopoietin-like 4 protein provide prognostic information in patients with suspected acute coronary syndrome. Journal of Internal Medicine. 1-16.
  • Show author(s) (2021). Activated factor XI-antithrombin complex presenting as an independent predictor of 30-days mortality in out-of-hospital cardiac arrest patients. Thrombosis Research. 1-8.
  • Show author(s) (2020). Transsulfuration metabolites and the association with incident atrial fibrillation – An observational cohort study among Norwegian patients with stable angina pectoris. International Journal of Cardiology. 75-80.
  • Show author(s) (2020). N-terminal pro-B-type natriuretic peptide as a prognostic indicator for 30-day mortality following out-of-hospital cardiac arrest: A prospective observational study. BMC Cardiovascular Disorders. 1-10.
  • Show author(s) (2020). Lipid parameters and vitamin A modify cardiovascular risk prediction by plasma neopterin. Heart. 1073-1079.
  • Show author(s) (2020). Effects of n-3 fatty acid supplementations in elderly patients after myocardial infarction: A randomized controlled trial. Circulation. 528-539.
  • Show author(s) (2020). Circulating trimethyllysine and risk of acute myocardial infarction in patients with suspected stable coronary heart disease. Journal of Internal Medicine. 446-456.
  • Show author(s) (2019). Effects of the PAR-1 Antagonist Vorapaxar on Platelet Activation and Coagulation Biomarkers in Patients with Stable Coronary Artery Disease. TH Open. e259-e262.
  • Show author(s) (2018). Plasma concentrations and dietary intakes of choline and betaine in association with atrial fibrillation risk: Results from 3 prospective cohorts with different health profiles. Journal of the American Heart Association (JAHA). 11 pages.
  • Show author(s) (2018). Plasma 25-hydroxyvitamin D and mortality in patients with suspected stable angina pectoris. Journal of Clinical Endocrinology and Metabolism (JCEM). 1161-1170.
  • Show author(s) (2018). Initial Phase NT-proBNP, but Not Copeptin and High-Sensitivity Cardiac Troponin-T Yielded Diagnostic and Prognostic Information in Addition to Clinical Assessment of Out-of-Hospital Cardiac Arrest Patients With Documented Ventricular Fibrillation. Frontiers in Cardiovascular Medicine. 1-11.
  • Show author(s) (2018). Increased plasma trimethylamine-N-oxide is associated with incident atrial fibrillation. International Journal of Cardiology. 7 pages.
  • Show author(s) (2018). Fibrinogen and Neopterin Is Associated with Future Myocardial Infarction and Total Mortality in Patients with Stable Coronary Artery Disease. Thrombosis and Haemostasis. 778-790.
  • Show author(s) (2018). Association of plasma neopterin with risk of an inpatient hospital diagnosis of atrial fibrillation: results from two prospective cohort studies. Journal of Internal Medicine. 578-587.
  • Show author(s) (2017). Vitamin D Uptake in Patients Treated with a High-Dosed Purified Omega-3 Compound in a Randomized Clinical Trial Following an Acute Myocardial Infarction. Frontiers in Cardiovascular Medicine. 6 pages.
  • Show author(s) (2017). The prognostic utility of dihomo-gamma-linolenic acid (DGLA) in patients with acute coronary heart disease. International Journal of Cardiology. 12-17.
  • Show author(s) (2016). Suggested Cut-Off Values for Vitamin D as a Risk Marker for Total and Cardiac Death in Patients with Suspected Acute Coronary Syndrome. Frontiers in Cardiovascular Medicine. 7 pages.
  • Show author(s) (2016). Long-term prognostic utility of pentraxin 3 and D-dimer as compared to high-sensitivity C-reactive protein and B-type natriuretic peptide in suspected acute coronary syndrome. European Journal of Preventive Cardiology (EJPC). 1130-1140.
  • Show author(s) (2016). Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease . New England Journal of Medicine. 1242-1252.
  • Show author(s) (2016). Cosinor modelling of seasonal variation in 25-hydroxyvitamin D concentrations in cardiovascular patients in Norway. European Journal of Clinical Nutrition. 517-522.
  • Show author(s) (2015). Use of loop diuretics is associated with increased mortality in patients with suspected coronary artery disease, but without systolic heart failure or renal impairment: an observational study using propensity score matching. PLOS ONE. 13 pages.
  • Show author(s) (2015). Prognostic utility of vitamin D in acute coronary syndrome patients in coastal Norway. Disease Markers. 11 pages.
  • Show author(s) (2015). Glycated hemoglobin and long-term prognosis in patients with suspected stable angina pectoris without diabetes mellitus: A prospective cohort study. Atherosclerosis. 115-120.
  • Show author(s) (2015). Elevated plasma dimethylglycine is a risk marker of mortality in patients with coronary heart disease. European Journal of Preventive Cardiology (EJPC). 743-752.
  • Show author(s) (2015). Borderline values of troponin-T and high sensitivity C-reactive protein did not predict 2-year mortality inTnT positive chest-pain patients, whereas brain natriuretic peptide did. Frontiers in Cardiovascular Medicine. 1-10.
  • Show author(s) (2015). Associations of plasma kynurenines with risk of acute myocardial infarction in patients with stable angina pectoris. Arteriosclerosis, Thrombosis and Vascular Biology. 455-462.
  • Show author(s) (2014). New ischemic stroke and outcomes with vorapaxar versus placebo: Results from the TRA 2°P-TIMI 50 trial. Journal of the American College of Cardiology. 2318-2326.
  • Show author(s) (2014). Comparison of Outcomes in Patients with ST-Segment Elevation Myocardial Infarction Discharged on Versus Not on Statin Therapy (from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction Trial). American Journal of Cardiology. 1273-1279.
  • Show author(s) (2013). Vitamin D predicts all-cause and cardiac mortality in females with suspected acute coronary syndrome: a comparison with brain natriuretic peptide and high-sensitivity C-reactive protein. Cardiology Research and Practice. 8 pages.
  • Show author(s) (2013). Socioeconomic assessment and impact of social security on outcome in patients admitted with suspected coronary chest pain in the city of Salta, Argentina. Cardiology Research and Practice. 1-9.
  • Show author(s) (2013). Relationship between the intensity of heparin anticoagulation and clinical outcomes in patients receiving glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in acute myocardial infarction. Catheterization and cardiovascular interventions. E9-E15.
  • Show author(s) (2013). Omega-3 index and prognosis in acute coronary chest pain patients with a low dietary intake of omega-3. Scandinavian Cardiovascular Journal. 69-79.
  • Show author(s) (2013). Long-term prognostic utility of PAPP-A and calprotectin in suspected acute coronary syndrome. Scandinavian Cardiovascular Journal. 88-97.
  • Show author(s) (2013). Long-term prognosis of patients presenting with ST-segment elevation myocardial infarction with no significant coronary artery disease (from The HORIZONS-AMI Trial). American Journal of Cardiology. 643-648.
  • Show author(s) (2013). Dietary intake of n-3 long-chain polyunsaturated fatty acids and risk of myocardial infarction in coronary artery disease patients with or without diabetes mellitus: a prospective cohort study. BMC Medicine.
  • Show author(s) (2013). Coronary Reperfusion and Clinical Outcomes After Thrombus Aspiration During Primary Percutaneous Coronary Intervention: Findings From the HORIZONS-AMI Trial. Catheterization and cardiovascular interventions. 594-601.
  • Show author(s) (2013). Cardiac resynchronization therapy improves minute ventilation/carbon dioxide production slope and skeletal muscle capillary density without reversal of skeletal muscle pathology or inflammation. Europace. 857-864.
  • Show author(s) (2012). Texture Analysis to Assess Risk of Serious Arrhythmias after Myocardial Infarction. Computers in cardiology. 365-368.
  • Show author(s) (2012). Serum 25(OH)D is a 2-year predictor of all-cause mortality, cardiac death and sudden cardiac death in chest pain patients from Northern Argentina. PLOS ONE.
  • Show author(s) (2012). Scand Cardiovasc J. 2012 Dec 12 [Epub ahead of print]. Omega-3 Index and prognosis in acute coronary chest pain patients with a low dietary intake of omega-3. Scandinavian Cardiovascular Journal.
  • Show author(s) (2012). Relationship between orthostatic hypotension and white matter hyperintensity load in older patients with mild dementia. PLOS ONE.
  • Show author(s) (2012). Omega-3 status and the relationship between plasma asymmetric dimethylarginine and risk of myocardial infarction in patients with suspected coronary artery disease. Cardiology Research and Practice. 11 pages.
  • Show author(s) (2012). Analysis of Intracardiac Electrogram Changes. Computers in cardiology. 669-672.
  • Show author(s) (2011). The heart rate of ventricular tachycardia following an old myocardial infarction is inversely related to the size of scarring. Europace. 864-868.
  • Show author(s) (2011). Low levels of the omega-3 index are associated with sudden cardiac arrest and remain stable in survivors in the subacute phase. Lipids. 151-161.
  • Show author(s) (2011). B-type natriuretic peptide and high sensitive C-reactive protein predict 2-year all cause mortality in chest pain patients: a prospective observational study from Salta, Argentina. BMC Cardiovascular Disorders. 11 pages.
  • Show author(s) (2010). The activity of pregnancy-associated plasma protein A (PAPP-A) as expressed by immunohistochemistry in atherothrombotic plaques obtained by aspiration thrombectomy in patients presenting with a ST-elevation myocardial infarction: a brief communication. Thrombosis Journal.
  • Show author(s) (2010). Long- and short-term effects of tobacco smoking on circulating concentrations of B vitamins. Clinical Chemistry. 755-763.
  • Show author(s) (2010). Dietary intake of n-3 long-chain polyunsaturated fatty acids and coronary events in Norwegian patients with coronary artery disease. American Journal of Clinical Nutrition. 244-251.
  • Show author(s) (2010). Coronary blood flow and perfusion pressure during coronary angiography in patients with ongoing mechanical chest compression: a report on 6 cases. Resuscitation. 493-497.
  • Show author(s) (2010). Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials. Journal of Internal Medicine. 367-382.
  • Show author(s) (2010). A history of late and very late stent thrombosis is not associated with increased activation of the contact system, a case control study. Thrombosis Journal. 6.
  • Show author(s) (2010). A comparison of the health status after percutaneous coronary intervention at a hospital with and without on-site cardiac surgical backup: a randomized trial in nonemergent patients. European Journal of Cardiovascular Prevention & Rehabilitation. 235-243.
  • Show author(s) (2009). The long pentraxin 3 (PTX3): a novel prognostic inflammatory marker for mortality in acute chest pain. Thrombosis and Haemostasis. 555-563.
  • Show author(s) (2009). High Prevalence of Orthostatic Hypotension in Mild Dementia. Dementia and Geriatric Cognitive Disorders. 307-313.
  • Show author(s) (2009). Cancer incidence and mortality after treatment with folic acid and vitamin B12. Journal of the American Medical Association (JAMA). 2119-2126.
  • Show author(s) (2009). Activated factor XII type A predicts long-term mortality in patients admitted with chest pain. Journal of Thrombosis and Haemostasis. 277-287.
  • Show author(s) (2009). Activated factor XII type A and B-type natriuretic peptide are complementary and incremental predictors of mortality in patients following admission with acute coronary syndrome. Blood Coagulation and Fibrinolysis. 652-660.
  • Show author(s) (2009). (n-3) Fatty Acid Content of Red Blood Cells Does Not Predict Risk of Future Cardiovascular Events following an Acute Coronary Syndrome. Journal of Nutrition. 507-513.
  • Show author(s) (2008). The prognostic utility of D-dimer and fibrin monomer at long-term follow-up after hospitalization with coronary chest pain. Blood Coagulation and Fibrinolysis. 701-707.
  • Show author(s) (2008). The long-term prognostic value of multiple biomarkers following a myocardial infarction. Thrombosis Research. 60-66.
  • Show author(s) (2008). Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography - A Randomized controlled trial. Journal of the American Medical Association (JAMA). 795-804.
  • Show author(s) (2008). Low levels of cellular omega-3 increase the risk of ventricular fibrillation during the acute ischaemic phase of a myocardial infarction. Resuscitation. 258-264.
  • Show author(s) (2008). Holotranscobalamin and methylmalonic acid as prognostic markers following an acute myocardial infarction. European Journal of Clinical Nutrition. 411-418.
  • Show author(s) (2008). Holotranscobalamin and methylmalonic acid as prognostic markers following an acute myocardial infarction. European Journal of Clinical Nutrition. 411-418.
  • Show author(s) (2008). Change to a primary PCI program increases number of patients offered reperfusion therapy and significantly reduces mortality. A real life experience evaluating the initiation of a primary PCI service at a single center without on site heart surgery in Western Norway. International Journal of Cardiology. 208-213.
  • Show author(s) (2008). Bivalirudin during primary PCI in acute myocardial infarction. New England Journal of Medicine. 2218-2230.
  • Show author(s) (2008). B-type natriuretic peptide is a long-term predictor of all-cause mortality, whereas high-sensitive C-reactive protein predicts recurrent short-term troponin T positive cardiac events in chest pain patients: a prognostic study. BMC Cardiovascular Disorders.
  • Show author(s) (2008). Activated Factor XII Type A Predicts Long-Term Mortality in Patients Admitted with Chest Pain. Journal of Thrombosis and Haemostasis. 277-287.
  • Show author(s) (2007). The effect of primary percutaneous coronary intervention as compared to tenecteplase on myeloperoxidase, pregnancy-associated plasma protein A, soluble fibrin and D-dimer in acute myocardial infarction. Thrombosis Research. 415-421.
  • Show author(s) (2007). Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease. Journal of Internal Medicine. 244-253.
  • Show author(s) (2007). Changes of plasma activated Factor XII type A (XIIaA) concentrations following percutaneous coronary intervention (PCI). Journal of Thrombosis and Thrombolysis. 131-135.
  • Show author(s) (2007). Cardiac arrest with continuous mechanical chest compression during percutaneous coronary intervention A report on the use of the LUCAS device. Resuscitation. 454-459.
  • Show author(s) (2007). Anomalies of the coronary arteries originating from the right sinus of Valsalva (1) Single coronary artery originating from the right sinus associated with fusion of the left and the non coronary cusp and atrophy of the left coronary ostium (2)Three separate coronary arteries originating from the right sinus of Valsalva. International Journal of Cardiology. e86-e89.
  • Show author(s) (2006). Specific types of activated Factor XII increase following thrombolytic therapy with tenecteplase. Journal of Thrombosis and Thrombolysis. 199-203.
  • Show author(s) (2006). Nonemergent coronary angioplasty without on-site surgical backup: A randomized study evaluating outcomes in low-risk patients. American Heart Journal. 888-895.
  • Show author(s) (2006). Long term influence of regular intake of high dose n-3 fatty acids on CD40-ligand, pregnancy-associated plasma protein A and matrix metal loproteinase-9 following acute myocardial infarction. Thrombosis and Haemostasis. 329-336.
  • Show author(s) (2006). Late complications following the deployment of drug eluting stents. International Journal of Cardiology. 398-401.
  • Show author(s) (2006). Homocysteine-lowering trials for prevention of cardiovascular events: A review of the design and power of the large randomized trials. American Heart Journal. 282-287.
  • Show author(s) (2006). Homocysteine-lowering trials for prevention of cardiovascular events: A review of the design and power of the large randomized trials. American Heart Journal. 282-287.
  • Show author(s) (2005). Thrombolysis and counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS Trial. Journal of Thrombosis and Thrombolysis. 33-39.
  • Show author(s) (2005). Persistent left superior vena cava. Use of an innominate vein between left and right superior caval veins for the placement of a right ventricular lead during ICD/CRT implantation. European Heart Journal. 2178.
  • Show author(s) (2004). Clinical outcome and atherothrombogenic risk profile after prolonged wash-out following long-term treatment with high doses of n-3 PUFAs in patients with an acute myocardial infarction. Clinical Nutrition. 491-500.
  • Show author(s) (2004). Activated factor 12 (FXIIa) predicts recurrent coronary events after an acute myocardial infarction. American Heart Journal. 260-266.
  • Show author(s) (2003). Reduction in homocysteine by n-3 polyunsaturated fatty acids after 1 year in a randomised double-blind study following an acute myocardial infarction: no effect on endothelial adhesion properties. Pathophysiol Haemost Thromb. 88-95.
  • Show author(s) (2003). Reduction in homocysteine by n-3 polyunsaturated fatty acids after 1 year in a randomised double-blind study following acute myocardial infarction: no effect on endothelial adhesion proteins. Pathophysiol Haemost Thromb. 88-95.
  • Show author(s) (2003). Increased lipid peroxidation during long-term intervention with high doses of n-3 fatty acids (PUFAs) following an acute myocardial infarction. European Journal of Clinical Nutrition. 793-800.
  • Show author(s) (2003). Increased lipid peroxidation during long-term intervention with high doses of n-3 fatty acids (PUFAs) following an acute myocardial infarction. European Journal of Clinical Nutrition. 793-800.
  • Show author(s) (2003). Changes in tissue factor and activated factor XII following an acute myocardial infarction were uninfluenced by high doses of n-3 polyunsaturated fatty acids. Thrombosis and Haemostasis. 752-759.
  • Show author(s) (2002). Characteristics and prognostic impact of plasma fibrin monomer (soluble fibrin) in patients with coronary artery disease. Blood Coagulation and Fibrinolysis. 301-308.
  • Show author(s) (2001). Reversed flow in internal mammary artery conduit and vertebral artery with left subclavian artery occlusion causing angina and vertigo. The coronary – subclavian steal syndrome. International Journal of Cardiology. 311-314.
  • Show author(s) (2001). Nytt PTCA-senter i Helseregion III. Hjerteforum. 21-22.
  • Show author(s) (2001). Effects of high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol. American Journal of Clinical Nutrition. 50-56.
  • Show author(s) (2001). Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol. American Journal of Clinical Nutrition. 50-56.
  • Show author(s) (2001). Beneficial changes in serum triacylglycerol and HDL-cholesterol by a high-dosed concentrate of n-3 fatty acids introduced early after an acute myocardial infarction did not improve prognosis compared to corn oil. American Journal of Clinical Nutrition. 50-56.
  • Show author(s) (2000). Plasma brain natriuretic peptide as a prognostic indicator in patients with preserved left ventricular systolic function after acute myocardial infarction. Circulation. 609.
  • Show author(s) (1999). Atherothrombogenic risk modulation by n-3 fatty acids was not associated with changes in homocysteine in subjects with combined hyperlipidaemia. Thrombosis and Haemostasis. 561-565.
  • Show author(s) (1993). Prognostic significance of N-terminal pro-atrial natriuretic factor (1-98) in acute myocardial infarction: comparison with atrial natriuretic factor (99-126) and clinical evaluation. British Heart Journal. 409-414.
  • Show author(s) (1993). Prognostic significance of N-terminal pro-atrial natriuretic factor (1-98) in acute myocardial infarction: comparison with artrial natriuretic factor (99-126) and clinical evaluation. British Heart Journal. 409-414.
  • Show author(s) (1993). Prognostic significance of N-terminal pro-atrial natriuretic factor (1-98) in acute myocardial infarction: Comparison with atrial natriuretic factor (99-126) and clinical evaluation. British Heart Journal. 409-414.
  • Show author(s) (1977). Systemic thrombin generation and activity resistant to low molecular weight heparin administered prior to streptokinase in patients with acute myocardial infarction. Thrombosis and Haemostasis. 57-61.
Academic lecture
  • Show author(s) (2022). Circulation 2022;146:A10315.The Effect of Protease-Activated Receptor-1 Inhibition With Vorapaxar in Post-mi and Nstemi Patients on Selected Biomarkers Reflecting Endothelial Function .
  • Show author(s) (2021). Circulation 2021 (Nov. 8); 144 (Suppl. 1): A9147. Reduced delta-6-desaturase activity may be associated with major adverse cardiac events during 2 years follow up in elderly patients with a recent myocardial infarction. .
  • Show author(s) (2020). Angiopoietin-2 is a long-term predictor of all-cause mortality, cardiac death and sudden cardiac death in chest-pain patients with suspected acute coronary syndrome.
  • Show author(s) (2018). Effects of the PAR­1 receptor antagonist vorapaxar on platelet activation and coagulation biomarkers in patients with stable coronary artery disease. EHJ 2018;39(Suppl.)50. Abstract 355.
  • Show author(s) (2016). The Prognostic Utility of Vitamin D Across Continents in Patients with Suspected Acute Coronary Syndrome. Circulation. 2016; 133: AP028.
  • Show author(s) (2015). Fibrinogen And Neopterin Predict Future Myocardial Infarction Events In Patients With Stable Coronary Heart Disease. Circulation. 2015;132:A19224.
  • Show author(s) (2013). Seasonal Discrepancy in the Correlation between Vitamin D and Omega-3 Index in Patients With Acute Coronary Syndrome from Western Norway. Circulation 2013; 128: A13208.
  • Show author(s) (2012). Vorapaxar in the secondary prevention of atherothrombotic events. N Engl J Med. 2012 Apr 12;366(15):1404-13. doi: 10.1056/NEJMoa1200933. Epub 2012 Mar 24. Dennis W.T. Nilsen (National investigator).
  • Show author(s) (2012). Thrombin-receptor antagonist vorapaxar in acute coronary syndromes. Dennis W.T. Nilsen (primary investigator). N Engl J Med. 2012 Jan 5;366(1):20-33. doi: 10.1056/NEJMoa1109719. Epub 2011 Nov 13.
  • Show author(s) (2012). Texture Analysis to Assess Risk of Serious Arrhythmias after Myocardial Infarction.
  • Show author(s) (2012). Circulation 2012;126:A19144(oral). New Ischemic Stroke and Outcomes with Vorapaxar vs. Placebo: Results from TRA 2°P-TIMI 50 Trial.
  • Show author(s) (2012). Circulation 2012;126:A13464(oral). Pentraxin 3 is Uninfluenced by High Doses of Concentrated Omega-3 Fatty Acids Administered for 12 Months Following an Acute Myocardial Infarction.
  • Show author(s) (2011). Vitamin D Status is a 2-Year Predictor of All-Cause Mortality and Cardiac Death in Chest Pain Patients: A Prognostic Study from Salta, Northern-Argentina. Circulation 2011; 124(21): Supplement. Abstract 10377.
  • Show author(s) (2010). Hjerteforum 2010, 23 (2): 77-80. Antitrombotisk behandling ved akutt koronarsykdom.
  • Show author(s) (2010). Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals.
  • Show author(s) (2010). Circulation. 2010;122:A10837. Abstract 10837: Brain Natriuretic Peptide, but Not Calprotectin or the Long Pentraxin 3 Independently Predicts Stroke in Long-Term Follow-up of Patients With Acute Coronary Syndrome.
  • Show author(s) (2010). Activated Factor XII as a risk predictor for cardiovascular disease.
  • Show author(s) (2009). Impact of Thrombus Aspiration in Patients with STEMI Undergoing Primary PCI: Analysis from the HORIZONS-AMI Trial. Circulation, Nov 2009; 120: S986. Abstract 4690.
  • Show author(s) (2009). Impact of Thrombus Aspiration during Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction: Analysis from the HORIZONS-AMI Trial. AJC 2009; 104(6) Suppl.: p 3D (Abstract 7).
  • Show author(s) (2008). Safety and effectiveness of bivalirudin compared to either abciximab or eptifibatide in patients with acute myocardial infarction undergoing primary angioplasty: The HORIZONS AMI trial. The SCAI Annual Scientific Sessions in Partnership with ACC i2 Summit. Chicago, March 29- April 1, 2008. Abstract 2900-28.
  • Show author(s) (2008). Impact of diabetes mellitus on the safety and effectiveness of bivalirudin in patients with acute myocardial infarction undergoing primary angioplasty: The HORIZONS AMI trial. The SCAI Annual Scientific Sessions in Partnership with ACC i2 Summit, Chicago, March 29- April 1, 2008. Abstract 2900-192.
  • Show author(s) (2008). Identification of patients who benefit from implantable cardioverter defibrillators (ICD) by combining the genotypes for Angiotensinogen (AGT),Angiotensin-converting enzyme (ACE) and Angiotensin II type1 receptor (AT1R).Circulation 2008;118(12):e414-e491(Abstract O62, e427).
  • Show author(s) (2007). WENBIT -Western Norway B-vitamin Intervention Trial: P96, Clinical Chemistry & Laboratory Medicine. 45(5):A18, May 2007.
  • Show author(s) (2007). WENBIT - Western Norway B-vitamin intervention trial.
  • Show author(s) (2007). The prognostic value of NT-proBNP versus PAPP-A, MPO and CD40L following a myocardial infarction. European Heart Journal 2007;Vol.28 (Abstract Supplement):265: abstract 1699.
  • Show author(s) (2006). Changes In Activated Factor XII From Admission To Day 4 Strongly Predict Recurrent Troponin-T Positive Cardiac Events At 30 Days Following Admission For Myocardial InfarctionPathophysiol Haemos Thromb2006; 35:199-248.
  • Show author(s) (2006). B-Type Natriuretic peptide is a predictor of all cause mortality at long-term follow-up after hospitalization with acute chest painEur Heart J 2006, 27(Abstract Suppl), 570.
  • Show author(s) (2006). Activated Factor XII type A strongly predicts all cause mortality after hospitalisation with TnT negative chest painEur Heart J 2006, 27(Abstract Suppl), 878.
  • Show author(s) (2006). Activated Factor XII Type A Strongly Predicts All Cause Mortality after Hospitalisation with Chest Pain.AACC Annual Meeting, 2006, Chicago, Abstract nr. D52.
  • Show author(s) (2005). Activated factor XII type A strongly predicts all cause mortality after hospitalisation with TnT negative chest pain. Circulation 2005;112(17):Suppl.II:p388,abstract 1903.
  • Show author(s) (2005). Activated factor XII provides better short-term prognostic information for a subsequent troponin-T positive event than other biomarkers in patients with myocardial infarction. J Thromb Haemost 2005;3:Suppl.1, OR155. ISSN:1740-3340.
  • Show author(s) (2002). Lessons learned from the Stavanger Secondary Prevention Trial.
  • Show author(s) (2002). Background diets rich in fish may mask the effect of high doses of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on clinical, despite an improvement in lipids.
  • Show author(s) (2001). Intra-aortic balloon pump therapy in cardiology – Stabilization and transport for surgery.
  • Show author(s) (2000). Trombolysis and counterpulsation to improve cardiogenic shock survival (TACTICS) Results of a prospective randomized trial.
  • Show author(s) (2000). Trombolysis and counterpulsation to improve cardiogenic shock survival (TACTICS) Results of a prospective randomized trial.
  • Show author(s) (2000). A randomised study to evaluate the clinical efficacy of a high dosed concentrate of n-3 fatty acids introduced early after an acute myocardial infarction.
  • Show author(s) (2000). A prospective randomized trial of thrombolysis and counterpulsation to improve cardiogenic shock survival: Preliminary results of the TACTICS trial.
  • Show author(s) (2000). A prospective randomized trial of thrombolysis and counterpulsation to improve cardiogenic shock survival: Preliminary results of the TACTICS trial.
Editorial
  • Show author(s) (2023). Prognostic Potential of Total Bilirubin in Secondary CVD Prevention. JACC: Asia. 252-254.
  • Show author(s) (2019). Editorial: Novel and potential markers for prediction of outcome in patients with acute and chronic coronary heart disease. Frontiers in Cardiovascular Medicine. 3 pages.
  • Show author(s) (2013). Potential Benefits of Ticagrelor beyond Platelet Inhibition. Cardiology. 31-33.
  • Show author(s) (2008). n-3 fatty acids and cardiovascular disease. Haematologica. 807-812.
Popular scientific article
  • Show author(s) (2012). BestPractice. Hjerte-karsykdommer 2012;2(4):20-24. Betydningsfulle prognosemarkører hos pasienter med koronarsuspekte brystsmerter. BestPractice Hjerte-karsykdommer: Faglig dialog mellom leger. 20-24.
Feature article
  • Show author(s) (2007). Homocysteine-lowerng trials for prevention of vascular disease: protocol for a collaborative meta-analysis. Clinical Chemistry and Laboratory Medicine. 1575-1581.
Letter to the editor
  • Show author(s) (2004). n-3 Fatty acids and cardiovascular disease. American Journal of Clinical Nutrition. 166.
Doctoral dissertation
  • Show author(s) (2022). Biomarkers related to outcome in patients with out-of-hospital cardiac arrest and in hospitalized patients with clinically suspected acute coronary syndrome. Suppl. 2.
  • Show author(s) (2017). Cardiovascular biomarkers as prognostic indicators in coronary chest pain patients.
  • Show author(s) (2016). Prognostic impact of vitamin D in coronary chest pain populations with high and low dietary intake of omega-3; comparison of a subtropical and a Nordic population.
  • Show author(s) (2013). Prognostic indicators of total-, cardiac- and sudden cardiac death in chest pain patients with suspected acute coronary syndrome (ACS); with special reference to socioeconomic class, B-type natriuretic peptide (BNP), high sensitivity C-reactive protein(hsCRP), vitamin D and the omega-3 index, https://bora.uib.no/handle/1956/6726.
  • Show author(s) (2010). The initiation and evaluation of a percutaneous coronary intervention program at a hospital without on-site cardial surgery in Western Norway.
  • Show author(s) (2010). N-3 fatty acids in relation to risk markers and clinical outcome in the acute coronary syndrome.
  • Show author(s) (2009). Studies on risk prediction in patients with chest pain and associations of the contact system to coronary heart disease, with reference to specific forms of activated Factor XII. Dissertation for the degree of philosophiae doctor (Ph.D), Institute of Medicine, Faculty of Medicine, University of Bergen, Norway, 06.11.2009.
  • Show author(s) (2009). Biomarkers for global risk assessment in the acute coronary syndrome. Dissertation for the degree of philosophiae doctor (Ph.D), University of Bergen, Norway, 27.11.2009.
  • Show author(s) (2004). Risk evaluation in atherothrombogenic populations receiving a high dose of n-3 fatty acids, with special reference to homocysteine, tissue factor, activated factor XII and peroxidation.
Abstract
  • Show author(s) (2013). THE LONG PENTRAXIN 3 DID NOT PREDICT OUTCOME WITHIN 45 MONTHS FOLLOW-UP IN PATIENTS FOLLOWING A SEVERE MYOCARDIAL INFARCTION. Journal of the American College of Cardiology. E185-E185.
  • Show author(s) (2012). Relationship between plasma choline and betaine levels and risk of acute myocardial infarction in patients with stable coronary heart disease. European Heart Journal. 132-132.
  • Show author(s) (2012). Plasma dimethylglycine is an independent risk factor of acute myocardial infarction in patients with stable angina pectoris. European Heart Journal. 510-510.
  • Show author(s) (2012). Long Pentraxin 3 (PTX3), Activated Factor XII type A (XIIaA) and B-type Natriuretic Peptide (BNP) did not independently predict stroke during seven years follow-up in patients admitted with chest pain. European Heart Journal. 236-236.
  • Show author(s) (2012). BNP, PTX3, and D-dimer are predictors of death, but only BNP is also a predictor of troponin-T positive cardiac events at long-term follow-up after hospitalization with acute chest pain. European Heart Journal. 947-947.
  • Show author(s) (2012). Activated factor XII type A independently predicts outcome during seven years follow-up in patients admitted with suspected acute coronary syndrome. European Heart Journal. 444-444.
  • Show author(s) (2010). Use of late gadolinium enhancement cardiovascular magnetic resonance images and texture analyses to distinguish patients with high and low risk of arrhythmias after myocardial infarction. European Heart Journal. 586-586.
  • Show author(s) (2010). A combination of novel biomarkers for coagulation (XIIaA), vascular inflammation (PTX3) and heart failure (BNP) enhances prognostic information in patients admitted with chest pain. European Heart Journal. 803-803.
  • Show author(s) (2009). Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. N Engl J Med. 2009 May 7;360(19):1946-59. New England Journal of Medicine.
  • Show author(s) (2009). Impact of Thrombus Aspiration during Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction: Analysis from the HORIZONS-AMI Trial. American Journal of Cardiology. 3D-4D.
  • Show author(s) (2009). Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2 degrees P)-TIMI 50 trial. Am Heart J. 2009 Sep;158(3):335-341.e3. American Heart Journal.
  • Show author(s) (2009). Dietary intake of very long chain n-3 fatty acids and cardiovascular events in Norwegian patients with coronary artery disease: a cohort study. European Journal of Cardiovascular Prevention & Rehabilitation. P340-P340.
  • Show author(s) (2009). Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial. Lancet. 2009 Oct 3;374(9696):1149-59. Epub 2009 Aug 28. The Lancet.
  • Show author(s) (2008). The relationship between serum lipids and quartiles of the omega-3 index in a beef eating population in Argentina as compared to a fish eating ACS population in Norway. Circulation. E254-E254.
  • Show author(s) (2008). The relationship between BNP and hsCRP and quartiles of the omega-3 index in a beef eating ACS population in Argentina as compared to a coastal ACS population in Norway. Circulation. E256-E256.
  • Show author(s) (2008). Serum triglycerides may reflect the content of cellular omega-3 fatty acids in CHD populations with a low intake of fish. Circulation. E261-E261.
  • Show author(s) (2008). Intracardiac electrocardiographic (EGM) morphology changes in patients with implantable cardioverter defibrillator (ICD). Circulation. 238.
  • Show author(s) (2008). Identification of patients who benefit from implantable cardioverter defibrillators (ICD) by combining the genotypes for Angiotensinogen (AGT), Angiotensin-converting enzyme (ACE) and Angiotensin II type1 receptor (AT1R). Circulation. 427.
  • Show author(s) (2008). Comparison of the omega-3 index in the acute coronary syndromes in a beef-eating population in Argentina as compared to a fish-eating population in Norway. Circulation. E439-E439.
  • Show author(s) (2008). Activated Factor XII type A is an independent predictor of cardiovascular outcome in coronary patients admitted with troponin T negative chest pain. Circulation. E194-E195.
  • Show author(s) (2008). Activated Factor XII and B-type natriuretic peptide, but not C-reactive protein, are independent predictors of mortality following admission with suspected myocardial infarction. Circulation. E194-E194.
  • Show author(s) (2006). No prognostic value of holo-transcobalamin or methylmalonic acid following an acute myocardial infarction. Circulation. 376.
  • Show author(s) (2005). B-Type Natriuretic peptide is not only a predictor of death, but also of troponin-T positive cardiac events at 6 months follow-up after hospitalisation with acute chest pain. European Heart Journal. 717-717.
  • Show author(s) (2004). Activated factor XII predicts troponin-T positive cardiac events at 30 days follow-up after hospitalization with acute chest pain. Circulation.
Poster
  • Show author(s) (2009). Would the use of N-terminal pro-B-type natriuretic peptide as a prognostic marker have changed our clinical judgement? Journal of Thrombosis and Haemostasis 2009; Volume 7, Supplement 2: Abstract PP-WE-830.
  • Show author(s) (2009). The value of d-dimer and fibrin monomer as prognostic markers of death at 30 days follow-up in chest pain patients with suspected acute coronary syndrome. Journal of Thrombosis and Haemostasis 2009; Volume 7, Supplement 2: Abstract PP-WE-829.
  • Show author(s) (2009). The value of calprotectin as a prognostic marker of cardiovascular risk in acute chest pain. European Heart Journal (2009)30(Abstract Supplement),472.
  • Show author(s) (2009). The relationship between the long pentraxin 3 and B-type natriuretic peptide in patients admitted with acute coronary syndromes. European Heart Journal (2009)30 (Abstract Supplement),135.
  • Show author(s) (2009). The plasma kallikrein-kinin system and clinical outcome during follow-up in chest-pain-patients. Journal of Thrombosis and Haemostasis 2009; Volume 7, Supplement 2: Abstract PP-TH-131.
  • Show author(s) (2009). The correlation of the long pentraxin 3 (PTX3) to lipids in patients hospitalized with acute chest pain. European Heart Journal (2009)30(Abstract Supplement),374.
  • Show author(s) (2009). Evaluation of plaque destabilization by pregnancy-associated plasma protein a (PAPPA) and coagulant activity did not predict reccurent Troponin-T positive cardiac events following an acute myocardial infarction. Journal of Thrombosis and Haemostasis 2009; Volume 7, Supplement 2: Abstract PP-WE-831.
  • Show author(s) (2009). Changes of inhibitory complexes of the plasma kallikrein-kinin system following percutaneous coronary intervention or thrombolytic therapy with tenecteplase. Journal of Thrombosis and Haemostasis 2009; Volume 7, Supplement 2: Abstract PP-WE-126.
  • Show author(s) (2009). A retrospective case control study on the role of hypercoagulability in late stent thrombosis. Journal of Thrombosis and Haemostasis 2009; Volume 7, Supplement 2: Abstract PP-TH-344.
  • Show author(s) (2009). A history of late stent thrombosis is not associated with increased activation of the contact phase system. Journal of Thrombosis and Haemostasis 2009; Volume 7, Supplement 2: Abstract PP-MO-433.
  • Show author(s) (2009). A case control study on platelet response to antiplatelet therapy in survivors of late stent thrombosis. Journal of Thrombosis and Haemostasis 2009; Volume 7, Supplement 2: Abstract PP-WE-072.
  • Show author(s) (2000). Influence on inflammatory markers of high-dose n-3 fatty acids after one year of treatment following an acute myocardial infarction.
Academic literature review
  • Show author(s) (2012). The Role of Long-Chained Marine N-3 Polyunsaturated Fatty Acids in Cardiovascular Disease. Cardiology Research and Practice. 15 pages.

More information in national current research information system (CRIStin)